Evonik Industries · 66-41 · GERMANY
For Evonik Industries · 66-41 · GERMANY, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is GERMANY; product is Ceramides Xblend | Ceramides Xblend; product code is 55 R - - 99 Pharmaceutic Necessities, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 08/15/2022; address is Rellinghauser Str. 1-11 , Essen, North Rhine-Westphalia GERMANY, verified against its source on 2026-09-16.
- Firm
- Evonik Industries verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- GERMANY verified
- Address
- Rellinghauser Str. 1-11 , Essen, North Rhine-Westphalia GERMANY verified
- Date published
- 08/15/2022 verified
- Product code
- 55 R - - 99 Pharmaceutic Necessities, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Ceramides Xblend | Ceramides Xblend each item verified
- FDA notes
- The product appears to be an unapproved new drug as the firm’s website, and product brochure labeling include, but are not limited to the following: “Helps to reduce transepidermal water loss”; “Helps to Improve Skin Barrier. A clinical study showed that balanced lipid mixtures containing ceramides are effective in improving skin barrier.”; “[V]olunteers using ceramide containing products had significantly better skin recovery after stress.”; “Helps to soothe contact dermatitis, allergic contact dermatitis, or atopic dermatitis”. | The product appears to be an unapproved new drug as the firm’s website, and product brochure labeling include, but are not limited to the following: “Helps to reduce transepidermal water loss”; “Helps to Improve Skin Barrier. A clinical study showed that balanced lipid mixtures containing ceramides are effective in improving skin barrier.”; “[V]olunteers using ceramide containing products had significantly better skin recovery after stress.”; “Helps to soothe contact dermatitis, allergic contact dermatitis, or atopic dermatitis”. each item verified
What the source says
Evonik Industries Date Published : 08/15/2022 Rellinghauser Str. 1-11 , Essen, North Rhine-Westphalia GERMANY 55 R - - 99 Pharmaceutic Necessities, N.E.C. Date Published: 08/15/2022 Desc: Ceramides Xblend Notes: The product appears to be an unapproved new drug as the firm’s website, and product brochure labeling include, but are not limited to the following: “Helps to reduce transepidermal water loss”; “Helps to Improve Skin Barrier. A clinical study showed that balanced lipid mixtures containing ceramides are effective in improving skin barrier.”; “[V]olunteers using ceramide containing products had significantly better skin recovery after stress.”; “Helps to soothe contact dermatitis, allergic contact dermatitis, or atopic dermatitis”. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 08/15/2022 Desc: Ceramides Xblend Notes: The product appears to be an unapproved new drug as the firm’s website, and product brochure labeling include, but are not limited to the following: “Helps to reduce transepidermal water loss”; “Helps to Improve Skin Barrier. A clinical study showed that balanced lipid mixtures containing ceramides are effective in improving skin barrier.”; “[V]olunteers using ceramide containing products had significantly better skin recovery after stress.”; “Helps to soothe contact dermatitis, allergic contact dermatitis, or atopic dermatitis”.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.